Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genome Diagnostics Laboratory, |
RCV002278143 | SCV002566342 | uncertain significance | Ehlers-Danlos syndrome | 2021-07-22 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004047534 | SCV005027933 | uncertain significance | Cardiovascular phenotype | 2023-12-04 | criteria provided, single submitter | clinical testing | The p.D2764N variant (also known as c.8290G>A), located in coding exon 23 of the TNXB gene, results from a G to A substitution at nucleotide position 8290. The aspartic acid at codon 2764 is replaced by asparagine, an amino acid with highly similar properties. This amino acid position is conserved. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |